Stamford, Connecticut – August 8, 2014- (Techsonian) –United Treatment Centers, (OTCMKTS:UTRM) DBA PotNetwork.tv offered updated information regarding the re-launch of the Company’s web site and upcoming streaming video news and content. James Wright, the Company’s new CEO said that the Company’s primary focus of being the go-to media source for everything cannabis remains constant. The Company’s new staff is dedicated to the development of content streaming to all platforms, such as computers and smart phones, as well as television distribution.
United Treatment Centers Inc (OTCMKTS:UTRM) gained volume of 59.78 million shares and the average volume of the stock remained 48.47 million shares. The 52 week range of the stock remained $0.0001 – $0.0146.The stock opened the session at $0.0007, and closed the session at $0.0006. The stock showed a negative performance of -14.29% in previous trading session.
Has UTRM Found The Bottom and Ready To Move Up? Find Out Here
Sylios Corp, (OTCMKTS:UNGS) announced that it has received approval from the Financial Industry Regulatory Authority for a change in the name of the Company.
In previous session, Sylios Corp (OTCMKTS:UNGS) traded 25.81 million shares and the average volume of the stock remained 30.52 million shares. The 52 week range of the stock remained $0.0004 – $0.0089. The stock was a bull and advanced 7.14%, while its closing price stayed at $0.0015.
For How Long UNGS Gloss will Attract Investors? Find out via this report
KOC HOLDINGS, (OTCMKTS:KHOLY) works in the energy, automotive, consumer durables, finance, and other sectors international. Its Energy segment markets and sells liquefied petroleum gas (LPG), liquefied natural gas, and water, as well as engaged in retail sale, storage, and trading of commercial and industrial fuels, and mineral oils through its 1,328 stations, including 921 stations under the OPET brand and 407 SUNPET stations under the SUNPET brand.
KOC HOLDINGS AS (OTCMKTS:KHOLY) volume of the stock was 13,743 shares in the most recent session and the average volume remained 22,017 shares. The stock declined -1.59% and finished the prior session at the closing price of $24.81.
Why Should Investors Buy KHOLY After the Recent Fall? Just Go Here and Find Out
Takeda Pharmaceutical, (OTCMKTS:TKPPY) is engaged in supplying pharmaceutical products worldwide. The company provides products in various therapeutic areas, including cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, and gastrointestinal and genitourinary, as well as vaccines. It is also involved in the manufacture and sale of OTC drugs and quasi-drugs, reagents, clinical diagnostics, and chemical products. The company has strategic alliance with MacroGenics, Inc. to develop DART for treatment of autoimmune disorders.
Technip (ADR) (OTCMKTS:TKPPY) traded with volume of 45,095 shares and the average volume of the stock remained 52,531 shares. The stock declined -1.60% and finished the trading at $22.19.
Will TKPPY Get Buyers Even After The Recent Rally? Find Out Here